Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Moodys
Cantor Fitzgerald
Federal Trade Commission
Chinese Patent Office
Johnson and Johnson
Queensland Health
Colorcon
Argus Health

Generated: January 16, 2019

DrugPatentWatch Database Preview

SER-A-GEN Drug Profile

« Back to Dashboard

Summary for SER-A-GEN
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 62
Formulation / Manufacturing:see details
DailyMed Link:SER-A-GEN at DailyMed
Drug patent expirations by year for SER-A-GEN

US Patents and Regulatory Information for SER-A-GEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay SER-A-GEN hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 087210-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fuji
Covington
Argus Health
Cipla
Healthtrust
Baxter
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.